0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Determining the Effects of Chronic Kidney Disease on Organic Anion Transporter1/3 Activity Through Physiologically Based Pharmacokinetic Modeling.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The renal excretion of drugs via organic anion transporters 1 and 3 (OAT1/3) is significantly decreased in patients with renal impairment. This study uses physiologically based pharmacokinetic models to quantify the reduction in OAT1/3-mediated secretion of drugs throughout varying stages of chronic kidney disease.

          Related collections

          Author and article information

          Journal
          Clin Pharmacokinet
          Clinical pharmacokinetics
          Springer Science and Business Media LLC
          1179-1926
          0312-5963
          Jul 2022
          : 61
          : 7
          Affiliations
          [1 ] School of Pharmacy, University of Waterloo, Waterloo, ON, Canada.
          [2 ] School of Pharmacy, University of Waterloo, Waterloo, ON, Canada. aedginto@uwaterloo.ca.
          Article
          10.1007/s40262-022-01121-6
          10.1007/s40262-022-01121-6
          35508593
          af19a1ce-df0c-4d87-b5c4-9df3064d6d8e
          History

          Comments

          Comment on this article